CHAE MILLER-WESTFIELD: Open Payments
NPI 1073050076 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 127 payments from 9 companies in 2025. Trend: 2023 $1,447 · 2024 $1,675 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 31 | $577 |
| Neurelis, Inc. | 41 | $373 |
| SK Life Science, Inc. | 23 | $228 |
| Otter Pharmaceuticals, LLC | 20 | $159 |
| Aucta Pharmaceuticals, Inc. | 7 | $79 |
| NOBELPHARMA AMERICA, LLC | 2 | $40 |
| BIOCODEX, INC. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| JAZZ PHARMACEUTICALS INC. | 1 | $17 |
Products named: VALTOCO, Fintepla, SYMPAZAN, Briviact, Nayzilam, Motpoly XR, HYFTOR, DIACOMIT.
Industry payments across NJ — which companies pay providers there.
